{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:34:39Z","timestamp":1777008879763,"version":"3.51.4"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Brain metastasis from colorectal cancer (CRC) is typically associated with advanced systemic disease and aggressive molecular features. CRC with wild-type KRAS\/BRAF, microsatellite stability, and low tumor mutational burden is generally considered to have a low risk of central nervous system (CNS) dissemination. We report the case of a 66-year-old woman with sigmoid colon adenocarcinoma who initially presented with locoregionally advanced disease and distant metastasis. She received neoadjuvant chemotherapy with six cycles of mFOLFOX regimen, followed by high anterior pelvic resection with covering ileostomy and then another six cycles of adjuvant chemotherapy, achieving apparent systemic remission on serial positron emission tomography\/computed tomography (PET\/CT) imaging. Molecular profiling revealed a microsatellite-stable tumor with low tumor mutational burden, wild-type KRAS\/NRAS\/BRAF, and a TP53 mutation. The patient developed delayed multiple brain metastasis more than 1 year after completion of systemic therapy with heterogeneously enhancing intracranial lesions with surrounding vasogenic edema. She underwent neuronavigation-guided craniotomy with near-total resection of the dominant lesion, and histopathology confirmed metastatic adenocarcinoma of colorectal origin. Overall, she had an unusual pattern of disease progression in molecularly low-risk CRC, indicating that delayed CNS metastasis can occur despite apparent systemic remission. These findings challenge current assumptions regarding CNS risk stratification in CRC and raise important questions about the need for individualized neurological surveillance strategies in selected patient subgroups.<\/jats:p>","DOI":"10.3389\/fonc.2026.1772072","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:34:34Z","timestamp":1777005274000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Cerebral metastasis following standard therapy in BRAF\/KRAS wild-type colorectal cancer: an unusual presentation of disease progression"],"prefix":"10.3389","volume":"16","author":[{"given":"Nazmin","family":"Ahmed","sequence":"first","affiliation":[{"name":"Ibrahim Cardiac Hospital and Research Institute","place":["Dhaka, Bangladesh"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal K.","family":"Chavda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurosurgery and Neurogenetics; Department of Clinical and Translational Research, ChromoMed Institute","place":["Santo Domingo, Dominican Republic"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Nazrul","family":"Hossain","sequence":"additional","affiliation":[{"name":"Ibrahim Cardiac Hospital and Research Institute","place":["Dhaka, Bangladesh"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s11864-022-00982-0","article-title":"Where are we now and where might we be headed in understanding and managing brain metastases in colorectal cancer patients","volume":"23","author":"Mjahed","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152531","article-title":"Survival in patients with colorectal cancer and isolated brain metastases: Temporal trends and prognostic factors from the National Cancer Database (2010\u20132020)","volume":"17","author":"Sarfraz","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-93084-4_41","article-title":"Metastatic disease of the lung","volume-title":"Cancer metastasis through the lymphovascular system","author":"Hammoud","year":"2022"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-023-00964-x","article-title":"Overall survival, BRAF, RAS, and MSI status in patients who underwent cetuximab after refractory chemotherapy for metastatic colorectal cancer","volume":"55","author":"Santos","year":"2024","journal-title":"J Gastrointest Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1038\/s41467-019-10987-3","article-title":"Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases","volume":"10","author":"Sun","year":"2019","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.03.075","article-title":"Genomic correlates of immune-cell infiltrates in colorectal carcinoma","volume":"15","author":"Giannakis","year":"2016","journal-title":"Cell Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.aai8515","article-title":"Origins of lymphatic and distant metastases in human colorectal cancer","volume":"357","author":"Naxerova","year":"2017","journal-title":"Sci (1979)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115268","article-title":"New frontiers of biomarkers in metastatic colorectal cancer: Potential and critical issues","volume":"26","author":"Medici","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1720","article-title":"KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer","volume":"17","author":"Tie","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae277","article-title":"Clinical impact of TP53 functional mutations in patients with metastatic colorectal cancer treated with bevacizumab and chemotherapy","volume":"30","author":"Ruzzo","year":"2025","journal-title":"Oncologist"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040900","article-title":"Brain metastases from colorectal cancer: A systematic review of the literature and meta-analysis to establish a guideline for daily treatment","volume":"13","author":"M\u00fcller","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.00.471","article-title":"The TP53 Colorectal Cancer International Collaborative Study on the prognostic and predictive significance of p53 mutation: Influence of tumor site, type of mutation, and adjuvant treatment","volume":"23","author":"Russo","year":"2005","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11060-010-0214-9","article-title":"Brain metastases from colorectal carcinoma: Prognostic factors and outcome","volume":"101","author":"Jung","year":"2011","journal-title":"J Neuro-Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.7636","article-title":"Brain tumor imaging","volume":"35","author":"Brindle","year":"2017","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-12-811161-1.00007-4","article-title":"Brain metastases: neuroimaging","volume":"149","author":"Pope","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa030","article-title":"Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases","volume":"22","author":"Kaufmann","year":"2020","journal-title":"Neuro Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S481656","article-title":"Molecular complexity of colorectal cancer: Pathways, biomarkers, and therapeutic strategies","volume":"16","author":"Yang","year":"2024","journal-title":"Cancer Manag Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/11795549231220320","article-title":"Artificial intelligence applications in the treatment of colorectal cancer: A narrative review","volume":"18","author":"Yang","year":"2024","journal-title":"Clin Med Insights Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41698-024-00592-z","article-title":"Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology","volume":"8","author":"Gustav","year":"2024","journal-title":"NPJ Precis Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1772072\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:35:05Z","timestamp":1777005305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1772072\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":19,"alternative-id":["10.3389\/fonc.2026.1772072"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1772072","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"1772072"}}